tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Crescent Biopharma sees cash runway through 2027

Cash was $152.6 million as of June 30, 2025, which is anticipated to fund operations through 2027.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1